What operational update did Elixir Energy (ASX:EXR) announce for its Lorelle-3H well?

Elixir Energy announced it is commencing the crucial stimulation, completion, and testing phase at its Lorelle-3H appraisal well in Queensland’s Taroom Trough. Operations begin on June 4 with a diagnostic fracture injection test (DFIT) at the toe end of the well.

Why is the Diagnostic Fracture Injection Test (DFIT) important for Elixir Energy (ASX:EXR)?

Conducted alongside Halliburton, the DFIT specifically measures reservoir pressures within the Tinowon 'Dunk' Sandstone. The test gathers critical data required to finalise the design of the subsequent multi-stage stimulation.

Which major oilfield service companies is Elixir Energy working with on this project?

Elixir Energy is collaborating with premier global energy services firms, including Halliburton, SLB (formerly Schlumberger), and Corelab. Halliburton is assisting with the immediate DFIT and RCD frameworks, while SLB and EnServe are partnering with Elixir for the upcoming flow-back and testing routine.

What are the key technical specs of the upcoming Lorelle-3H stimulation programme?

The engineering team has designed a massive six-million-pound, 11-stage stimulation programme utilizing physical core and petrophysical data from the Lorelle-3 and 3H wells. All procurement, contracting, and preparatory works for this phase are already complete.

What is the timeline for Elixir Energy's (ASX:EXR) operations in June?

The DFIT begins on June 4, followed by the main 11-stage stimulation operations in mid-June. Immediately after stimulation, an intensive flow-back and testing routine formulated with EnServe will commence in late June. Investors should expect steady operational news flow throughout the month.

What is the ultimate goal of Elixir Energy’s current testing phase?

The final stage of the program aims to deliver the vital IP30 production curve for the Lorelle-3H well. An IP30 metric represents the average initial production rate of gas or oil over the well's first 30 days. This serves as the primary commercial proof-of-concept needed to validate the asset's economic viability.

Image for illustrative purposes only. Not a real photo.

Elixir Energy advances Lorelle-3H well operations

Written by Mahathir BayenaPublished Jun. 4 2026

Elixir Energy (ASX:EXR) announced a pivotal operational update for its high-impact Lorelle-3H appraisal well, situated in ATP2056 within Queensland’s Taroom Trough.

The company is set to commence the crucial stimulation, completion, and testing phase on June 4, starting with a diagnostic fracture injection test.

Initiated alongside industry heavyweight Halliburton at the toe end of the well, the DFIT is specifically designed to measure reservoir pressures within the Tinowon 'Dunk' Sandstone.

The process will gather critical data required to finalise the design of the subsequent multi-stage stimulation and testing phase.

Collaborative engineering work alongside experts from SLB, Corelab, and Halliburton RCD is now largely complete.

Utilising physical core and petrophysical data recovered from the Lorelle-3 and 3H wells, the team has designed a six-million-pound, 11-stage stimulation programme under Elixir’s pre-approved RCD framework.

Procurement, contracting, and preparatory works for this next phase have already concluded, with operations scheduled to commence in mid-June.

The stimulation will be immediately followed by an intensive flow-back and testing routine. Elixir, in partnership with EnServe, has already formulated the testing plan, with operations slated to begin in late June.

The final stage aims to deliver the vital IP30 production curve for the Lorelle-3H well.

At the time of reporting, Elixir Energy’s share price was $0.11.